161. Why sharing patents for COVID-19 medicines is not enough
Despite the Medicines Patent Pool, COVID-19 treatments remain scarce globally. Prashant Yadav explains what more is needed.
How the war in Iran will disrupt medical supplies around the world
The Gulf states are not large producers of pharmaceuticals or healthcare products - but the oil they supply, and the transport infrastructure they have built, are key components in a worldwide logistical network that underpin all of the pharmaceutical and other medical consumables we use.
From cri…
Will the War Stop Your Medicine?
Tim Elliott interviews Prashant Yadav, Senior Fellow for Global Health at the Council on Foreign Relations, to examine escalating threats to global healthcare logistics amidst regional instability. They analyse how the pharmaceutical industry is adapting, alongside the strategic shifts and inventor…
Anna Titkova & Prashant Yadav: When War Stops a Patient's Treatment
Two wars, a pandemic threat, and a regulatory system under strain are hitting global health at the same time. Anna Titkova, who led clinical operations in Ukraine through the invasion, and Prashant Yadav of the Council on Foreign Relations, one of the world's leading voices on healthcare supply cha…
How Demand for GLP-1s Overwhelmed the Global Drug System
GLP-1 drugs such as Ozempic have become some of the world's most-wanted medicines, but soaring demand has also turned them into a stress test for the global drug system. On this episode of Why It Matters, Gabrielle Sierra and CFR Senior Fellow Prashant Yadav trace how the GLP-1 trend led to shortag…
PODKAST SØGEMOTOR
Du kan bruke vår nettsted til å søke etter3,821,555podkaster og195,372,593episoder etter personer, steder eller emner.
If I have seen further than others, it is by listening to podcasts and standing upon the shoulders of
giants.
‐ Isaac "Llamacorn" Newton
REDIG
Takk fordi du hjelper med å holde podkast-databasen oppdatert.
